Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Acute Charcot Neuroarthropathy Diagnosis and Management

Clinical Presentation and Diagnosis

  • The presence of bounding pulses with warm skin indicates hyperemia, not infection, representing the inflammatory phase of Charcot neuroarthropathy where increased blood flow causes bone resorption, as noted by the Infectious Diseases Society of America 1, 2
  • Normal laboratory values, such as normal inflammatory markers and absence of leukocytosis, argue strongly against infection, according to the American Diabetes Association 3, 4
  • The absence of wound or ulceration is a key distinguishing feature, as diabetic foot infections typically require a portal of entry, usually through an ulcer, as stated by the Infectious Diseases Society of America 5, 1
  • Bilateral warmth and bounding pulses without purulent discharge are characteristic of Charcot neuroarthropathy, not infection, as indicated by the American Diabetes Association 1, 2, 6

Immediate Management

  • Institute complete non-weight-bearing status immediately to prevent progressive bone and joint destruction, as recommended by the Infectious Diseases Society of America 1, 2
  • Apply a total contact cast or removable walker rendered irremovable once acute Charcot is confirmed, according to the American Diabetes Association, although this specific recommendation is not preferred due to its origin from Praxis Medical Insights 7
  • Urgent referral to a multidisciplinary diabetic foot team within 24-48 hours is necessary for definitive diagnosis and management, as stated by the Infectious Diseases Society of America and the American Diabetes Association 1, 2, 7

Diagnostic Confirmation

  • Obtain plain radiographs of the foot to look for fractures, subluxation, or bone fragmentation, although early Charcot may show normal X-rays, as noted by the Infectious Diseases Society of America and the American Diabetes Association 5, 3
  • Consider MRI if diagnosis is uncertain to differentiate Charcot from osteomyelitis or soft tissue infection, as MRI is more sensitive and specific for detecting bone and soft tissue pathology, according to the American Diabetes Association 5, 3
  • Measure foot temperature differential, as a difference >2°C between affected and contralateral foot supports Charcot diagnosis, as indicated by the American Diabetes Association 3, 4

Rule Out Infection

  • Carefully examine for any breaks in skin integrity or ulceration, as infection becomes a consideration and requires tissue culture if present, as stated by the Infectious Diseases Society of America, while avoiding a recommendation from Praxis Medical Insights 1, 6
  • Probe any wounds to bone if ulceration is found, as this suggests osteomyelitis, although this specific action's recommendation is not preferred due to its origin from Praxis Medical Insights 7
  • Do not start empiric antibiotics without evidence of infection, as this promotes antimicrobial resistance, as recommended by the Infectious Diseases Society of America and the American Diabetes Association 1, 2, 7

Common Pitfalls to Avoid

  • Mistaking acute Charcot for cellulitis or infection and treating with antibiotics alone while allowing continued weight-bearing leads to irreversible foot deformity and future ulceration, as noted by the Infectious Diseases Society of America and the American Diabetes Association 1, 3
  • Failing to recognize that neuropathy masks pain, making clinical assessment challenging, as stated by the American Diabetes Association 3, 4
  • Delaying offloading while awaiting imaging, as immobilization should begin immediately based on clinical suspicion, not after radiographic confirmation, according to the Infectious Diseases Society of America, while avoiding a less preferred recommendation from Praxis Medical Insights 1, 7

When to Reconsider Infection

  • Reassess for infection if purulent discharge from any wound, skin breakdown or ulceration with ≥2 inflammatory signs, systemic signs emerge, or clinical deterioration despite appropriate Charcot management occurs, as stated by the Infectious Diseases Society of America, the American Diabetes Association, and while being cautious of recommendations from Praxis Medical Insights 1, 6, 3, 2, 7